[CD34(+)/CD123(+) cell sorting from the patients with leukemia by Midi MACS method].

Area of Science:

• Hematology
• Cell Biology
• Biotechnology

Context:

• Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
• Identifying and isolating specific cell populations like CD34(+) and CD34(+)/CD123(+) cells is critical for AML research and potential therapies.
• Current cell sorting methods may have limitations in terms of efficiency or accessibility.

Purpose:

• To evaluate the efficacy of the Midi MACS (Magnetic-Activated Cell Sorting) method for isolating CD34(+) and CD34(+)/CD123(+) cells from bone marrow of AML patients.
• To assess the enrichment and recovery rates of the sorted cell populations using fluorescence-activated cell sorting (FACS).

Summary:

• Bone marrow mononuclear cells (BMMNCs) from AML patients were processed using Ficoll Paque.
• CD34(+) cells were isolated via Midi MACS, followed by isolation of CD34(+)/CD123(+) cells from the CD34(+) fraction.
• FACS analysis confirmed high enrichment (up to 99.23%) and recovery (average 56% from CD34+ fraction) of CD34(+)/CD123(+) cells using Midi MACS.

Impact:

• The Midi MACS method provides a viable and efficient alternative for isolating specific cell populations in AML research.
• Successful isolation of CD34(+)/CD123(+) cells can facilitate further studies into their role in AML pathogenesis and treatment.
• The findings suggest potential for improved cell-based therapies and diagnostic approaches in AML.